Cite
THE EFFECT OF DAPAGLIFLOZIN ON DAYS OF FULL HEALTH LOST DUE TO DEATH, HOSPITALIZATION, AND IMPAIRED WELL-BEING IN DAPA-HF.
MLA
Kondo, Toru, et al. “The Effect of Dapagliflozin on Days of Full Health Lost Due to Death, Hospitalization, and Impaired Well-Being in Dapa-Hf.” Journal of the American College of Cardiology (JACC), vol. 83, no. 13, Apr. 2024, p. 318. EBSCOhost, https://doi.org/10.1016/S0735-1097(24)02308-8.
APA
Kondo, T., Mogensen, U. M., Talebi, A., Gasparyan, S., campbell, ross, Docherty, K. F., De Boer, R. A., Inzucchi, S. E., K, ber, L., Kosiborod, M., Martinez, F. A., Sabatine, M. S., Bengtsson, O., Sjoestrand, M., Vaduganathan, M., Solomon, S. D., Jhund, P. S., & McMurray, J. J. V. (2024). The Effect of Dapagliflozin on Days of Full Health Lost Due to Death, Hospitalization, and Impaired Well-Being in Dapa-Hf. Journal of the American College of Cardiology (JACC), 83(13), 318. https://doi.org/10.1016/S0735-1097(24)02308-8
Chicago
Kondo, Toru, Ulrik Madvig Mogensen, Atefeh Talebi, Samvel Gasparyan, ross campbell, Kieran F. Docherty, Rudolf A. De Boer, et al. 2024. “The Effect of Dapagliflozin on Days of Full Health Lost Due to Death, Hospitalization, and Impaired Well-Being in Dapa-Hf.” Journal of the American College of Cardiology (JACC) 83 (13): 318. doi:10.1016/S0735-1097(24)02308-8.